Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Marvell Technology (MRVL) : "The top is nowhere close to here. This stock could go to $30. "
Albemarle (ALB) : "I don't think this story is done. Don't trade it, be in it."
Credit Acceptance (CACC) : "I like the stock but if you have a nice gain, let's be careful."
Realty Income (O) : "I think this stock is expensive and one you should exit form."
Houlihan Lokey (HLI) : "This is a niche business and I like it. There is a place for them. This is a good stock."
Edwards Lifesciences (EW) : "These downgrades are from knuckle heads. This company has the better mousetrap."
Cramer and the AAP team analyze the 2018 roadmap for Allergan (AGN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS
Over on Real Money, Cramer says always remember that on Wall Street, artifice is a major mover of stocks. Get more on his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
More of What's Trending on TheStreet:
- Did Intel's Embattled CEO Just Shock Everyone at CES?
- Toyota Partners With Amazon, Uber on These Crazy Self-Driving Mobile Stores
- Apple's iPhone Addiction Issue Unlikely to Impact Shares Anytime Soon: Analysts
- Why Stocks Now Have an 83.7% Chance of Rising in 2018
At the time of publication, Cramer's Action Alerts PLUS had a position in AGN.